Skip to main content

Advertisement

Table 5 The features of operation and postoperative complications in patients with APGC

From: Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study

  NSR (n = 572) CR (n = 152) SPR (n = 113) P
Operation time (min) 192 ± 13 241 ± 21 221 ± 7 < 0.001a
Intraoperativetransfusion 154 (26.9%) 68 (44.7%) 36 (31.8%) < 0.001b
Postoperativehospital stay (days) 12.63 ± 1.45 15.25 ± 2.86 12.86 ± 1.68 < 0.001a
Examined lymph nodes 25.11 ± 13.71 28.38 ± 14.47 27.02 ± 11.32 0.018a
Non-lethal Complication 48 (8.4%) 34 (22.4%) 14 (12.4%) < 0.001b
Anastomotic leakage 14 7 3  
Pancreas-related complications 6 10 0  
Lung pleura- related complications 7 6 2  
Wound complication 5 2 3  
Postoperative ileus 13 6 5  
Liver dysfunction 3 3 0  
Mortality* 3 9 1 NS
Postoperative chemotherapy     0.118
Presence 406(69.4%) 96(16.4%) 83(14.2%)  
Absence 166(65.9%) 56(22.2%) 30(11.9%)  
  1. NSR: Nosplenic hilar orsplenic arteryLN resection;APGC: Advanced proximal gastric cancer
  2. a: one-way anova,b:χ2test; *:these patients had excluded from the study